Search Results 421-430 of 21306 for anti-TNF drugs

1. Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma - Mayo Clinic

   Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma · Overview · Participation ...

2. Anakinra (Subcutaneous Route) Proper Use - Mayo Clinic

   Proper Use. Drug information provided by: Merative, Micromedex®. COVID-19: A doctor or other trained health professional will give you this medicine ...

3. Ibuprofen (Oral Route) Before Using - Mayo Clinic

   Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding. Drug Interactions. Although certain medicines ...

4. Antidepressants and weight gain: What causes it? - Mayo Clinic

   Many factors can contribute to weight gain during antidepressant therapy. For example: Overeating or inactivity as a result of depression can cause weight gain.

5. Flecainide (Oral Route) Description and Brand Names - Mayo Clinic

   Flecainide belongs to the group of medicines known as antiarrhythmics. It works directly on the heart tissue and will slow the nerve impulses in the heart.

6. Sickle cell anemia - Diagnosis & treatment - Mayo Clinic

   Treatments might include medicines and blood transfusions. For some children and teenagers, a stem cell transplant might cure the disease. Gene therapies also ...

7. A Study to Evaluate Intra-arterial Delivery of Mesenchymal Stem Cells for Luminal Ulcerative Colitis - Mayo Clinic

   Concurrent therapies with corticosteroids, 5-ASA drugs, thiopurines, MTX, antibiotics, anti-TNF, and anti-integrin therapy are permitted. To meet the ...

8. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... [anti-TNF] agents) within 2 weeks prior to randomization. Patients who have ...

9. Vedolizumab (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Entyvio. Descriptions. Vedolizumab injection is used to ...

10. Atezolizumab (Intravenous Route) Description and Brand Names - Mayo Clinic

    Atezolizumab injection is also used alone as first-line treatment for metastatic (cancer that has already spread) non-small cell lung cancer (NSCLC) in ...